A study has been carried out to explore the impact by varying the number of arcs and beam arrangement on dose distributions. For this volumetric modulated arc therapy and 7-field, intensity-modulated radiation therapy plans have use for prostate cancer cases. The eclipse treatment planning system version 13.6 (Varian California, USA) was used to assess dosimetry data for 20 patients. All patients received intensity-modulated radiation therapy and volumetric modulated arc therapy plans with a varying number of arcs. 6MV X-Ray photon beam energy uses for each patient. Statistical plan assessments have been carried out for various dosimetric parameters to evaluate execution efficiency. There were no statistically significant changes (p>0.05) observed in D98% dose coverage while D2%, conformity index, homogeneity index, monitor unit, and treatment delivery time were showing statistically significant changes (p<0.05). In contrast to six arc volumetric modulated arc therapy and 7 field-intensity-modulated radiation therapy plans, Single arc volumetric modulated arc therapy plans showed 23.28 % and 25.96 % less monitor unit, 97.52 % and 137.53 % less treatment delivery time. It concluded that using a higher number of arcs in volumetric modulated arc therapy plans for prostate cancer improves plan efficiency. The four arc volumetric modulated arc therapy plans appeared to provide a reasonable trade-off between enhanced treatment delivery time and high treatment plan quality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.